TYGACIL (tigecycline) Pf prism cv Patent: 9,254,328 Expiration: Mar 13, 2026 See More … For more information on how DrugPatentWatch […]
Drug Patent Expirations for the Week of March 8, 2026 Read Post »
Part One: What GPT-Rosalind Is and What OpenAI Is Selling The Model Architecture GPT-Rosalind is the first in what OpenAI
GPT-Rosalind and Generic Drugs: What OpenAI’s Life Sciences Model Actually Changes Read Post »
A systematic, intelligence-led playbook for commercial and market access vendors targeting pre-LOE mandates with health plans, PBMs, IDNs, and brand
Beat the Patent Cliff: How to Trigger Payer Strategy Campaigns Before Drug Patent LOE Read Post »
The launch of OpenAI GPT-Rosalind on April 17, 2026, marks the end of the traditional patent cliff as a predictable
OpenAI’s GPT-Rosalind = Smashed Drug Patent Cliffs and 70% Faster ANDAs Read Post »
The Generic Entry Problem Nobody States Plainly Every branded pharmaceutical product has a clock on it. The moment the FDA
Why the GCC Derails Pharma IP Teams That Know the U.S. System Cold There is a particular category of expensive
Know Exactly How Long Your Drug Patent Lasts in the GCC Read Post »
The Notice That Never Gets Sent Pharmaceutical companies do not issue press releases announcing lifecycle extension campaigns. They do not
Read the Patent Trail: 4 Signals Your Competitor Is Extending a Drug’s Life Read Post »
Executive Summary Most biopharma packaging sales reps knock on the wrong doors at the wrong time. They call on brand-side
On April 16, 2026, OpenAI did something it had never done before: it shipped a model designed not to chat,
GPT-Rosalind: What OpenAI’s Life Sciences Model Actually Does to Drug Development Read Post »
Get fresh news and insights, drug patent expirations & more…
